-
INTERPHEX Unveils Conference Programming For May 2012 Event
2/10/2012
The organizers and Advisory Board of INTERPHEX have reengineered the 2012 conference program, to be held at New York's Javits Center on May 1-3, 2012.
-
Courtagen To Partner With Tetracore In Biodefense Initiative
2/10/2012
Courtagen Life Sciences, Inc. ("Courtagen"), a privately held life sciences company that provides innovative proteomic and genomic products and services to the life sciences industry, recently announced that it has entered into a strategic collaboration with Tetracore, Inc. ("Tetracore") to develop a next generation biothreat assay for identifying and diagnosing high priority biological agents in clinical and environmental samples.
-
Why Bad Immunity Genes Survive
2/10/2012
University of Utah biologists found new evidence why mice, people and other vertebrate animals carry thousands of varieties of genes to make immune-system proteins named MHCs – even though some of those genes make us susceptible to infections and to autoimmune diseases.
-
Cytomedix Expands Commitment To Regenerative Medicine With Acquisition Of Aldagen
2/10/2012
Cytomedix, Inc. (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announces the completion of the acquisition of Aldagen, Inc., a privately held biopharmaceutical company developing regenerative cell therapies based on its proprietary ALDH bright cell ("ALDHbr") technology.
-
Researchers Uncover New Mechanism In Multiple Myeloma Cells
2/10/2012
Researchers at Virginia Commonwealth University Massey Cancer Center have discovered a mechanism in multiple myeloma cells that plays a critical role in the cells' ability to resist treatments involving a class of drugs known as histone deacetylase inhibitors (HDACIs).
-
Treatment For TB Can Be Guided By Patients’ Genetics
2/10/2012
A gene that influences the inflammatory response to infection may also predict the effectiveness of drug treatment for a deadly form of tuberculosis. By Leila Gray
-
Integrated DNA Technologies Acquires 1st BASE Oligonucleotide Business In Singapore
2/10/2012
Integrated DNA Technologies (IDT) has acquired the oligonucleotide business of Singapore's top supplier in the field, 1st BASE Pte. Ltd (1st BASE).
-
Roche’s xCELLigence Cardio Instrument Used To Detect Beating Rhythm And Proarrhythmic Effects Of Compounds In Stem Cell-Derived Cardiomyocytes
2/10/2012
In an effort to improve preclinical cardiotoxicity assays, reduce drug testing attrition rates, and ensure drug safety, collaborating scientists at the University Medical Center Utrecht in the Netherlands, and Bioscience Department of AstraZeneca R&D, Mölndal, Sweden, have tested Roche's xCELLigence Cardio Instrument.
-
Good Timing: NIST/CU Collaboration Adds Timing Capability To Living Cell Sensors
2/9/2012
Individual cells modified to act as sensors using fluorescence are already useful tools in biochemistry, but now they can add good timing to their resumé, thanks in part to expertise from the National Institute of Standards and Technology (NIST).
-
NIST Announces Program To ID Human Cell Lines For Research
2/9/2012
The National Institute of Standards and Technology (NIST) has announced that it is launching a project to collect and catalog DNA identification data for up to 1,500 human cell lines used in biological and medical research.
